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Background/aim: In this study, our aim was to investigate the neutrophil/lymphocyte (N/L) ratio, variations in leukocytes and leukocyte
subtypes, and the relationship between N/L ratio and insulin resistance (IR) in obesity.
Materials and methods: Ninety-six patients and 40 healthy controls were included in this study. Patients’ blood glucose levels, insulin
levels, and hemogram parameters upon 8 h of fasting were determined. Body mass index (BMI) and Homeostasis Model AssessmentInsulin Resistance (HOMA-IR) values were calculated.
Results: Neutrophil numbers were found to be higher among obese patients with IR than among non-IR obese patients. The N/L ratio
was, moreover, found to be higher among obese patients with IR when compared to non-IR obese patients. A positive correlation was
found between insulin resistance and both neutrophil and WBC counts. Positive correlations were also found between insulin levels and
the N/L ratio, WBC counts, and neutrophil counts.
Conclusion: In our study, leukocyte numbers and subtypes were determined to be higher among obese individuals than among healthy
individuals. The N/L ratio was increased significantly only among obese patients with IR. Further studies are needed in order to better
demonstrate the relationship between the N/L ratio and IR/inflammation.
Key words: Neutrophil-lymphocyte ratio, obesity, insulin resistance

1. Introduction
Obesity is increasingly becoming a major public health
problem worldwide. Its prevalence has spiked dramatically
over the past 20 years. In the United States, 35.7% of
adults are obese, while in Turkey 32% of adults are
obese (1). Obesity has a negative impact on many tissues
and systems in the body that are associated with many
various mechanisms. Inflammation is certainly one of the
most important of these mechanisms. Obesity-induced
microinflammation has been shown in different studies
using different biomarkers (2). For example, obesity has
been shown to be positively associated with increased
levels of CRP, an increased white blood cell (WBC) count,
and an increased number of leukocyte subtypes (2). The
neutrophil-lymphocyte ratio (N/L ratio) is known to be
associated with inflammation. For example, it has been
shown to be associated with subclinical inflammation

both in certain malignancy types and in coronary artery
disease (3–7). Although the role of inflammation in
obesity and insulin resistance (IR) is well known, there
nevertheless remains a lack of sufficient data with regards
to the N/L ratio. Thus, this study has been geared towards
investigating how the N/L ratio, leukocytes, and their
subtypes are affected among obese patients.
2. Materials and methods
The data from 250 obese patients were scanned
retrospectively, out of which 96 patients who fit the
inclusion criteria and had complete file information
were included in the study. The inclusion criteria were
predefined as patients being 18 years of age and older,
with a body mass index (BMI) of ≥25 kg/m2; having no
systemic diseases such as arterial hypertension, diabetes,
or metabolic abnormality; having no active or chronic

* Correspondence: drserdarkarakaya@gmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

245

KARAKAYA et al. / Turk J Med Sci
infectious or inflammatory diseases; and not being a part
of any ongoing drug treatment. The inclusion criteria for
the control group were defined as being healthy individuals
having a BMI of <25 kg/m2, having neither active nor
chronic diseases, and not taking part in any ongoing drug
treatment. Forty healthy individuals from among 120
people who were admitted to the hospital for check-ups
were selected as the control group in accordance with
the inclusion criteria. Patients’ demographic data such as
age, sex, height, and weight were also recorded. BMI was
calculated as follows: BMI = weight (kg)/height squared
(m2). Patients’ blood glucose and insulin levels, as well
WBC, neutrophil and lymphocyte counts and N/L ratios
following a minimum of 8 h of fasting were obtained from
their medical records.
Patients’ levels of IR were calculated according to
the following formula: Homeostasis Model Assessment
(HOMA)-IR= fasting plasma glucose × fasting insulin/405.
HOMA-IR of ≥3 is accepted as insulin resistance (8). The
results of both the patient and control groups were then
recorded into an SPSS database, whereupon all statistical
analysis was performed using SPSS 18.0. Parametric
tests were used to compare the data between groups and
variables. Pearson correlation analysis was used in order to
evaluate the relationships between each variable. P < 0.05
was considered to be statistically significant.
3. Results
Ninety-six patients and 40 healthy controls were included
in this study. There was no statistical difference between
the groups in terms of age and sex (Table 1). White
blood cell counts were significantly higher in obese
patients (8764 ± 2023 and 7712 ± 1932, respectively, P =
0.006). Neutrophil and lymphocyte numbers were also
significantly higher among the obese group relative to
the control group (neutrophils: 5359 ± 1788 and 4585 ±

1473, respectively, P = 0.02; lymphocytes: 2615 ± 627 and
2287 ± 553, respectively, P = 0.005). However, there was no
statistically significant difference for the N/L ratio between
groups (2.18 ± 1.00 and 2.10 ± 0.83, respectively, P = 0.7).
When the patient group was examined for insulin
resistance (HOMA-IR ≥3), there was no statistically
significant difference among obese individuals without
IR (51 patients in total) and obese individuals with IR (46
patients in total) with respect to age and sex (Table 2).
Neutrophil numbers were found to be higher among obese
patients with IR than among non-IR obese patients (5780
± 1628 and 4980 ± 1838, P = 0.02). No statistical difference
was found between IR obese and non-IR obese patients in
terms of lymphocyte numbers (2595 ± 625 and 2649 ± 637,
P = 0.7). The N/L ratio, however, was found to be higher
in IR obese patients when compared to their non-IR obese
counterparts (2.39 ± 1.06 vs. 1.97 ± 0.91, P = 0.04).
Correlation analysis of both the patient and control
groups revealed a positive correlation between IR and
both neutrophils and WBC counts (neutrophils: r = 0.331,
P = 0.001; WBC: r = 0.377, P < 0.001). Other positive
correlations were found for N/L ratio, WBC counts, and
neutrophil numbers (N/L ratio: r = 0.215, P = 0.03; WBC:
r = 0.410, P < 0.001; neutrophils: r = 0.368, P < 0.001).
4. Discussion
In our study, we observed that neutrophil and lymphocyte
numbers were higher among obese individuals than
among nonobese individuals while the N/L ratio was
similar between the two groups. However, among obese
patients, we observed that as the level of IR increased, so
did both the N/L ratio and the number of leukocytes and
their subtypes.
The relationship between inflammation and obesity is
now very well established. Leukocytes, being responsible
for a portion of this relationship, infiltrate fat tissue and

Table 1. Laboratory parameters of obese and nonobese individuals.
Control (n = 40)

Obesity (n = 96)

P-value

Age (years)

33.38 ± 9.41

36.75 ± 11.11

0.09

Sex (F/M)

31/9

78/18

0.4

BMI (kg/m )

22.14 ± 2.61

32.71 ± 5.57

<0.001

Neutrophils (/µL)

4585 ± 1473

5359 ± 1788

0.02

Lymphocytes (/µL)

2287 ± 553

2615 ± 627

0.005

N/L ratio

2.10 ± 0.83

2.18 ± 1.01

0.7

WBCs (/µL)

7712 ± 1932

8764 ± 2023

0.006

2

BMI: Body mass index, N/L ratio: neutrophil/lymphocyte ratio, WBC: white blood cell.
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Table 2. Laboratory parameters of obese individuals with insulin resistance and obese
individuals without insulin resistance.
Non-IR obese patients IR obese patients
(n = 51)
(n = 46)

P-value

Age (years)

36.63 ± 11.20

36.89 ± 11.01

0.9

Sex (F/M)

43/8

36/10

0.08

BMI (kg/m2)

30.52 ± 3.82

35.00 ± 6.37

<0.001

Insulin (mIU/mL)

9.38 ± 2.79

20.32 ± 6.06

<0.001

HOMA-IR

2.04 ± 0.62

4.61 ± 1.44

<0.001

Neutrophils (/µL)

4980 ± 1838

5780 ± 1628

0.03

Lymphocytes (/µL)

2649 ± 637

2595 ± 625

0.9

N/L ratio

1.98 ± 0.91

2.39 ± 1.06

0.04

WBCs (/µL)

8386 ± 2156

9276 ± 1857

0.03

BMI: Body mass index, HOMA-IR: Homeostasis Model Assessment-Insulin Resistance,
N/L ratio: neutrophil/lymphocyte ratio, WBC: white blood cell.

release inflammatory cytokines (9,10). Metaanalysis
showed that there was an increase in circulating white
blood cells among obese patients, thus posing a high risk
for type 2 diabetes (11). A relationship was also found
between circulating leukocyte subtypes and IR among
diabetic people, with additional risk factors (12). Previous
studies revealed a strong correlation between leukocyte
number (a clinical inflammation marker) and subtypes
and obesity (13).
Unlike many previous studies, obese individuals who
had no additional risk factor were investigated in our
study. We analyzed the relationship between obesity and
inflammation in obese and nonobese groups according
to both insulin levels and IR. Neutrophil, lymphocyte,
and white blood cell numbers were statistically different
between the obese and nonobese group. Among the
patient group, N/L ratios were found to be significantly
higher in those with versus those without IR. This finding
shows us that the difference in N/L ratio with obesity is
linked to a rise in IR. The lack of statistical significance
between the groups, however, may be due to the fact not
every obese patient was found have IR.
There was a significant difference in terms of
neutrophils and white blood cell counts between the
two groups divided according to IR. This shows us that
BMI and levels of leukocyte/leukocyte subtypes increase
concomitantly.
Therefore, according to our findings, it seems that
obesity ought to be considered as one of the causes
of an increase in leukocytes and leukocyte subtypes.
Similar findings have also been previously documented

among diabetic patients. The increase in the number of
neutrophils, lymphocytes, and leukocytes in individuals
at high risk for developing diabetes has been shown to
support subclinical inflammation (14).
The findings of our study furthermore suggest that
obese people with no additional risk factors nevertheless
have a common mechanism, e.g., diabetes. However, our
study reveals that there is an increase in levels of both
neutrophils and lymphocytes, which in turn implies
that the N/L ratio can explain the further increase in
neutrophil number as insulin level increases. What
has also been demonstrated is that there is a positive
correlation between insulin levels and leukocyte and
neutrophil numbers (15). Our study reveals that there is
a positive correlation between the N/L ratio and insulin
level.
These differences may be due to lack of number of
cases in previous studies. These results support that
increment in insulin level increases inflammation via
inflammatory mediators. The lack of other markers of
inflammation (e.g., CRP and sedimentation), coupled by
a lack of demographic data (e.g., waist circumference),
constitute the limitations of our study.
In conclusion, data emerging from our study indicate
that the N/L ratio may be used as a marker for obese
individuals who have high IR. Accordingly, the increase
in the neutrophil, lymphocyte, and leukocyte numbers
among obese patients who lack any additional health
complications being a possible result of IR should be kept
in mind. However, we believe that further studies are
needed in this regard.
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